Hebei Medical University Fourth Hospital

This study is testing whether adding a targeted radiation treatment to a two-drug immunotherapy regimen can better shrink liver tumors that cannot initially be removed by surgery. The goal is to see if this combination can make surgery possible for more patients. It will involve …

This study is testing whether the drug olaparib can help control recurrent triple-negative breast cancer in patients who don't have the typical BRCA gene mutations. The trial will enroll 30 women with advanced breast cancer that has returned or spread. Researchers want to see if …

This study is testing a new treatment approach for people with locally advanced rectal cancer that has not spread to distant organs. It combines a shorter, more intense course of radiation with chemotherapy and a new immunotherapy drug called enlonstobart, given before surgery. T…

This study is testing if a targeted drug called befotertinib, when combined with radiation, can better control a specific type of advanced lung cancer that has spread to only a few places. It will enroll 84 adults with a certain genetic change (EGFR mutation) in their cancer. Doc…